EDX Medical Group

EDX Medical Group

Medical and Diagnostic Laboratories

Cambridge, Cambridgeshire 563 followers

Developing innovative diagnostics to enable personalised treatment for cancer, heart disease and infectious diseases.

About us

EDX Medical Group PLC develops innovative digital diagnostic products and services, enabling personalised treatment for cancer, heart disease and infectious diseases. The company is listed on the Access Segment of the AQSE Growth Market (TIDM: EDX). EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally. EDX Medical Group operates a molecular biology and diagnostics laboratory in Cambridge, UK, and 100%-owned subsidiary companies, Hutano Diagnostics Limited in Oxford, UK, and Torax Biosciences Ltd in Ireland. EDX Medical provides testing and genomic sequencing services, undertakes quality assurance, conducts research & development (R&D) and has established expertise in the design, development, validation and sourcing of diagnostic testing solutions to ISO 13485. Key laboratory tests performed by the Company have been accredited to ISO 15189 by the United Kingdom Accreditation Service (UKAS).

Industry
Medical and Diagnostic Laboratories
Company size
11-50 employees
Headquarters
Cambridge, Cambridgeshire
Type
Public Company
Founded
2022

Locations

  • Primary

    211 Cambridge Science Park

    Cambridge, Cambridgeshire CB4 0WA, GB

    Get directions

Employees at EDX Medical Group

Updates

Similar pages

Funding

EDX Medical Group 1 total round

Last Round

Seed

US$ 2.2M

See more info on crunchbase